Medical Device Regulation in Estonia
Estonia regulates medical devices under the EU Medical Device Regulation (EU MDR 2017/745). The State Agency of Medicines (Ravimiamet) serves as the national competent authority. Estonia is known for its advanced digital governance and e-health infrastructure, and it fully implements the EU harmonized regulatory framework for medical devices.
Recent Regulatory Updates
Showing the latest 1 updates. Sign up to see more
Sources Tracked by Qalico
Qalico continuously monitors 1 references across guidelines, regulations, and standards for Estonia.
Guidelines
Device Classification
Estonia follows the EU MDR risk-based classification system. Class I devices are low risk (e.g., simple wound dressings, reading glasses). Class IIa devices are low-moderate risk (e.g., powered hearing aids, surgical clamps). Class IIb devices are moderate-high risk (e.g., incubators for newborns, external bone fixation systems). Class III devices are high risk (e.g., drug-eluting stents, total knee prostheses). Classification is determined per EU MDR Annex VIII.
Official classification guidance →Official Guidance Documents
Official information from Estonia's State Agency of Medicines on medical device regulation and compliance requirements.
The complete text of EU Regulation 2017/745 on medical devices, directly applicable in Estonia.
The European database for medical device registration and UDI management across all EU member states.
Standards & Key Principles
Applicable Standards
Key Principles
- Medical devices must bear the CE mark under EU MDR 2017/745 to be placed on the Estonian market.
- EUDAMED registration and UDI compliance are required.
- Higher-risk devices (Class IIa, IIb, III) require notified body involvement.
- Non-EU manufacturers must have an EU-based authorized representative.
- Vigilance and post-market surveillance obligations must be fulfilled with the State Agency of Medicines.
Pre-Market Requirements
Devices must comply with EU MDR 2017/745 and bear CE marking. Notified body involvement is required for Class IIa, IIb, and III devices.
Full technical documentation per EU MDR Annexes II and III must be prepared and maintained.
Clinical evaluations are mandatory for all device classes. Clinical investigations in Estonia require SAM authorization and ethics committee review.
Manufacturers must register in EUDAMED with actor, device, and UDI information.
Post-Market Requirements
Manufacturers must implement PMS systems per EU MDR. PSURs are required for Class IIa, IIb, and III devices.
Serious incidents and field safety corrective actions must be reported to the State Agency of Medicines per EU MDR timelines.
PMCF activities must be ongoing to confirm continued safety and performance of devices.
International Recognition & Reliance
As an EU member state, CE-marked devices are recognized throughout the EU/EEA single market.
CE-marked devices from EU member states are recognized in Switzerland under the Swiss-EU MRA.